Insider trade

Bruker (BRKR)Officer sold ~$88K

Mark Munch, Officer at Bruker, sold ~$88K of Bruker shares.

~$88K
Approx. value · 2,000 sh @ $43.90: 128K
Holds after · shares reported

Traded: May 15, 2026
Filed: May 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Mar 13, 2026InsiderOfficer sold ~$71K of BRKR shares in the open market
Apr 1, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 27, 2026, the Board of Directors (the “Board”) of Bruker Corporation (the “Company”) approved an increase in the number of directors to expand the size of the Board by one director to a total of twelve directors, with such additional director assigned to Class III, and appointed Thierry L. Bernard to fill the newly created vacancy on the Board, effective as of April 1, 2026.”
Apr 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 6, 2026, Bruker Corporation (the “Company”) and Falko Busse, Ph.D., an executive officer of the Company and President of the Bruker BioSpin Group (“Bruker BioSpin”), a wholly owned subsidiary of the Company, agreed that his duties as executive officer with the Company and as President of Bruker BioSpin would transition on or around May 1, 2026 and that his employment with the Company and Bruker BioSpin…”
Apr 15, 2026InsiderOfficer sold ~$80K of BRKR shares in the open market
May 6, 2026Company filing · Form 8-K · ResultsReported its results
May 15, 2026 · this disclosureInsiderOfficer sold ~$88K of BRKR shares in the open market

What came next

Jun 15, 2026InsiderOfficer sold ~$110K of BRKR shares in the open market
Jul 15, 2026InsiderOfficer sold ~$121K of BRKR shares in the open market
Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
Aug 14, 2026InsiderOfficer sold ~$115K of BRKR shares in the open market
Aug 17, 2026InsiderOfficer sold ~$198K of BRKR shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bruker

For Bruker, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BRKR page.

Other recent filings by Mark Munch, EXEC VP&PRES BRUKER NANO INC.

The full history of Mark Munch, EXEC VP&PRES BRUKER NANO INC. is on the profile page.

How this filing works

Other disclosures at Bruker

Everything OQRO holds on this company is on its BRKR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data